Anti-Recombinant Phospho-Chk1 (Ser345), clone 9C1

Anti-Recombinant Phospho-Chk1 (Ser345), clone 9C1
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-AN301324L.100 100 µl -

7 - 16 Werktage*

391,00 €
 
The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for... mehr
Produktinformationen "Anti-Recombinant Phospho-Chk1 (Ser345), clone 9C1"
The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for checkpoint mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA. This protein acts to integrate signals from ATM and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I. Phosphorylation of CDC25A protein phosphatase by this protein is required for cells to delay cell cycle progression in response to double-strand DNA breaks. Several alternatively spliced transcript variants have been found for this gene.
Schlagworte: Anti-CHEK1, Anti-Checkpoint kinase-1, Anti-CHK1 checkpoint homolog, Anti-Cell cycle checkpoint kinase, Anti-Serine/threonine-protein kinase Chk1, Recombinant Phospho-Chk1 (Ser345) Monoclonal Antibody
Hersteller: Elabscience
Hersteller-Nr: E-AN301324L

Eigenschaften

Anwendung: WB
Antikörper-Typ: Monoclonal
Klon: 9C1
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse, rat
Immunogen: A synthetic peptide corresponding to residues around (Ser345) of Human Phospho-Chk1
MW: 56 kD

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Signalwort: Warning
GHS-Piktogramme:
H-Sätze: H317
P-Sätze: P261, P272, P280, P302+352, P333+313
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Recombinant Phospho-Chk1 (Ser345), clone 9C1"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen